Verified Treatment Center
The Baywood Center Queensbury
Queensbury, NY · 12804
Key Takeaways for The Baywood Center Queensbury
- • IOP · MAT · Dual Dx offered
- • Accepts Medicaid, Private insurance
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About The Baywood Center Queensbury
Located in Queensbury, NY, The Baywood Center Queensbury operates within the NY regulatory framework as a licensed addiction-treatment provider. The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.
Care levels at The Baywood Center Queensbury
Level-of-care documentation: The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.
Insurance and payment
Payment and insurance posture: The Baywood Center Queensbury accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.
Specialty programming
The facility's documented specialty programming includes: Adolescents, Young adults, Adult women. Specialty-program verification requires review of: (a) dedicated specialty-track programming hours per week; (b) specialty-credentialed clinical staffing (e.g., LCSW with trauma specialization, perinatal-nurse certification, adolescent-development training); (c) specialty-specific clinical assessment protocols; (d) specialty-specific outcome measurement. Marketing designation alone is insufficient for clinical confidence.
Before you call
Pre-admission documentation for The Baywood Center Queensbury should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
The Baywood Center Queensbury at a Glance
Levels of care
IOP · MAT · Dual Dx
Service settings
Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Therapy approaches
Brief intervention, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy
Age groups
Children/Adolescents
Special populations
Adolescents, Young adults, Adult women, Adult men, Veterans, Active duty military
Medications
Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.